Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,420.00    4.00 (0.28%)
Bid:
1,426.00
Ask:
1,430.00
Spread: 4.00 (0.281%)
Market Cap: £486.17m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement and Board Changes

21 Nov 2025 07:00

RNS Number : 4496I
Craneware plc
21 November 2025
 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement and Board Changes

 

21 November 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, provides an update on trading ahead of its Annual General Meeting, taking place at 10am today.

 

The Board is pleased to confirm that following the growth reported in FY25, the start of FY26 has seen the positive momentum continue. Alongside the Group's direct sales efforts, the alliance with Microsoft is progressing well, adding significant sales pipeline growth as well as continuing to help drive innovation. US healthcare providers remain focused on optimising their operational and financial performance, driving demand for the Group's solutions.

 

The Group continues to invest in R&D to strengthen its product set, leveraging its proprietary data assets to expand its offerings and launch new AI enabled applications. A recent area of focus has been the accelerated development of a product to support customers through the 340B drug rebate pilot program, whereby participating hospitals have to purchase an initial 9 named drugs at wholesale acquisition cost and later apply for manufacturer rebates. This program, announced on 30 October 2025 by the Health Resources and Services Administration ("HRSA"), is due to commence on 1 January 2026, creating further operational and administrative complexities for healthcare providers. As a result of prior investments in the Trisus platform, the depth of Craneware's data and its unique position of independence in the 340B vendor market, the Company has successfully brought this fully integrated solution to market in an accelerated timeframe, supporting its customers by reducing their financial risk, maintaining compliance and protecting resources for patient care. Having demonstrated the product through live meetings and a series of webinars, the solution is now being rolled out ahead of the deadline and is a testament to Craneware's leading position in the 340B market.

 

Board Changes

 

As previously announced, following many years of service on the Board of Directors, David Kemp, Senior Non-Executive Director, has decided not to stand for re-election at the Company's AGM later today and as a result, will retire from the Board following the close of the meeting. The Board thanks him for his significant contributions during his tenure. His insight and constructive challenge have been invaluable, helping drive Craneware's success.

 

Following the completion of the AGM, Alistair Erskine will assume the role of Senior Independent Director, Susan Nelson will assume the role of Chair of the Audit Committee and Jill Goldsmith will take over the role of Company Secretary to the Board.

 

Outlook

 

The strength of the Company's Annuity SaaS business model and balance sheet, its high levels of recurring revenue and strong cash generation provide Craneware with solid foundations as it executes on its growth strategy and the creation of long-term value for all stakeholders.

 

The Board remains confident in the delivery of continued growth over the near term, and the Group continues to trade in line with market expectations for the year.

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma Strategic Communications

+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters

craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Arnav Kapoor

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Patrick Dologhan

 

About Craneware

 

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFFFSILRLIFIE
Date   Source Headline
2nd Jul 20127:00 amRNSTrading Update
15th Jun 201210:57 amRNSTotal Voting Rights
31st May 201212:32 pmRNSHolding(s) in Company
29th May 20121:03 pmRNSHolding(s) in Company
28th May 20124:14 pmRNSHolding(s) in Company
28th May 20124:11 pmRNSHolding(s) in Company
8th May 20125:41 pmRNSHolding(s) in Company
27th Apr 20125:09 pmRNSHolding(s) in Company
26th Apr 20124:17 pmRNSHolding(s) in Company
26th Apr 20123:46 pmRNSHolding(s) in Company
23rd Apr 20126:14 pmRNSTotal Voting Rights
23rd Apr 20126:13 pmRNSBlocklisting Interim Review
16th Apr 201212:57 pmRNSHolding(s) in Company
30th Mar 201212:36 pmRNSHolding(s) in Company
29th Mar 20125:02 pmRNSHolding(s) in Company
28th Mar 20123:39 pmRNSHolding(s) in Company
20th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20125:51 pmRNSDividend Currency Election
8th Mar 201212:57 pmRNSHolding(s) in Company
5th Mar 201212:17 pmRNSTotal Voting Rights
2nd Mar 20123:24 pmRNSHolding(s) in Company
29th Feb 20125:43 pmRNSHolding(s) in Company
28th Feb 20124:29 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSChannel Partner Contract Win
28th Feb 20127:00 amRNSHalf Yearly Report
17th Feb 20123:29 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSNotice of Results
31st Jan 201210:00 amRNSHolding(s) in Company
16th Jan 20123:40 pmRNSHolding(s) in Company
12th Jan 20126:28 pmRNSHolding(s) in Company
11th Jan 20124:55 pmRNSHolding(s) in Company
10th Jan 20127:00 amRNSTrading Update
11th Nov 20111:14 pmRNSDividend Currency Election
10th Nov 201110:36 amRNSResult of AGM
10th Nov 20117:00 amRNSAGM Statement
1st Nov 20115:39 pmRNSTotal Voting Rights
1st Nov 201112:29 pmRNSBlocklisting Interim Review
25th Oct 20111:42 pmRNSDirector/PDMR Shareholding
18th Oct 20112:26 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20114:43 pmRNSTotal Voting Rights
26th Sep 20117:00 amRNSGrant of Options
31st Aug 201111:53 amRNSDirector/PDMR Shareholding
30th Aug 20117:00 amRNSFinal Results
22nd Aug 20115:02 pmRNSHolding(s) in Company
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20113:49 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSTrading Update and Contract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.